Micoy Therapeutics is a pioneering biotechnology company dedicated to revolutionizing the treatment of life-threatening viral infections and cancer. Driven by groundbreaking research, we have identified a significant population at risk due to the presence of harmful autoantibodies that impair the immune system's ability to combat viruses or respond effectively to anticancer therapy.
Our innovative approach leverages advanced computational biology to design targeted therapies that neutralize these rogue autoantibodies, restoring normal immune function and protecting individuals from a wide range of viral threats. By addressing a previously overlooked vulnerability, we aim to save countless lives and improve global health outcomes.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Jersey City, Nj, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Biotechnology Research.
- HQ
- Jersey City, NJ
Micoy Therapeutics Questions
Micoy Therapeutics's website is https://www.micoytherapeutics.com/
Micoy Therapeutics's LinkedIn profile is https://www.linkedin.com/company/micoy-therapeutics
Micoy Therapeutics has
5 employees.
View email and phone details for 5
employees at Micoy Therapeutics.
Micoy Therapeutics's industry is
Biotechnology Research
Micoy Therapeutics's top competitors are
Salivadirect, Inc.,
Maipl Therapeutics, Inc.,
Cellipont Bioservices,
Anvesana,
Md-Phd Program Columbia University,
Rumi Scientific,
Redesign Science,
Beacon Scientific,
Mirimus,
Ny Bio.
Micoy Therapeutics's categories are Biotechnology Research
Micoy Therapeutics's founding year is 2024
